STRATA Skin Sciences (SSKN) Equity Average (2011 - 2025)

STRATA Skin Sciences' Equity Average history runs 15 years deep, the most recent figure standing at $2.1 million for Q4 2025.

• In Q4 2025, Equity Average fell 70.63% year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (down 70.63% YoY), while the FY2025 annual figure was $3.9 million, down 55.38% from the prior year.
• Equity Average came in at $2.1 million for Q4 2025 at STRATA Skin Sciences, up from $923000.0 in the prior quarter.
• In the past five years, Equity Average ranged from a high of $26.0 million in Q3 2021 to a low of $923000.0 in Q3 2025.
• A 5-year average of $15.4 million and a median of $17.3 million in 2023 frame the typical range for Equity Average.
• Across the five-year window, Equity Average slipped 0.43% in 2021 and sank 90.24% in 2025, its largest moves.
• STRATA Skin Sciences' Equity Average stood at $25.8 million in 2021, then decreased by 15.44% to $21.8 million in 2022, then plunged by 33.81% to $14.4 million in 2023, then sank by 50.23% to $7.2 million in 2024, then sank by 70.63% to $2.1 million in 2025.
• According to Business Quant data, Equity Average over the past three periods registered $2.1 million, $923000.0, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison